摘要
以2-氨基-5-氯苯甲酸甲酯为原料,经五步反应制得7-氯-5-氧代-2,3,4,5-四氢-1H-苯氮杂卓艹(2);2与5-硝基吡啶-2-甲酰氯(或对硝基苯甲酰氯)发生N-酰化反应,再经SnCl2还原制得关键中间体4a(或4b);在4的氨基上引入取代苯甲酰基或苯磺酰基合成了15个具有潜在AVP-V2受体抑制作用的新型托伐普坦类似物(5a~5k,6b,6i,7b和8d),其结构经1H NMR,IR和MS表征。SD大鼠利尿活性试验表明,5~8均有一定的利尿活性,且部分化合物活性较高。
7-Chloro-5-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine(2) was prepared by a five-step reaction from methyl 2-amino-5-chlorobenzoate.Two key intermediates,4a and 4b,was prepared by N-acetylation of 2 with 5-nitrylpyridine-2-carbamoyl chloride or p-nitrylbenzoyl chlorid,then reduction in the presence of SnCl2.Fifteen novel potential inhibition of the AVP-V2 receptors,tolvaptan derivatives(5a~5k,6b,6i,7b and 8d) were synthesized by introducing substituted-benzoyl or substituted-phenyl-sulfonyl at amino of 4.The structures were characterized by 1H NMR,IR and MS.The SD rats diuretic test showed that some of them exhibited better diuretic activities.
出处
《合成化学》
CAS
CSCD
北大核心
2012年第5期543-549,共7页
Chinese Journal of Synthetic Chemistry
基金
国家重大新药创制专项(2011ZX09401-009)